REKYNRA

Pharmaceutical preparations for the treatment of stroke; pharmaceuticals for the treatment of neurological disease, pharmaceuticals for the treatment of ischemia, pharmaceuticals for the treatment of neuronal injury, and pharmaceuticals for the treatment of neurodegenerative diseases; pharmaceuticals and pharmaceutical preparations for the treatment of subarachnoid hemorrhage, strokes associated with vascular interventions, traumatic brain injury, surgical brain injuries, radiation-induced brain injuries, concussions, pain, anxiety, epilepsy, neuronal damage associated with epilepsy, Alzheimer's, tinnitus, retinal ischemia, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis